BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 10964839)

  • 21. Detailed histopathologic characterization of the retinopathy, globe enlarged (rge) chick phenotype.
    Montiani-Ferreira F; Fischer A; Cernuda-Cernuda R; Kiupel M; DeGrip WJ; Sherry D; Cho SS; Shaw GC; Evans MG; Hocking PM; Petersen-Jones SM
    Mol Vis; 2005 Jan; 11():11-27. PubMed ID: 15660021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered gene expression in the eye of a mouse model for batten disease.
    Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and molecular characterization of non-syndromic retinal dystrophy due to c.175G>A mutation in ceroid lipofuscinosis neuronal 3 (CLN3).
    Chen FK; Zhang X; Eintracht J; Zhang D; Arunachalam S; Thompson JA; Chelva E; Mallon D; Chen SC; McLaren T; Lamey T; De Roach J; McLenachan S
    Doc Ophthalmol; 2019 Feb; 138(1):55-70. PubMed ID: 30446867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CNTF induces dose-dependent alterations in retinal morphology in normal and rcd-1 canine retina.
    Zeiss CJ; Allore HG; Towle V; Tao W
    Exp Eye Res; 2006 Mar; 82(3):395-404. PubMed ID: 16143329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic effects of mutant GUCY2D in Leber congenital amaurosis.
    Milam AH; Barakat MR; Gupta N; Rose L; Aleman TS; Pianta MJ; Cideciyan AV; Sheffield VC; Stone EM; Jacobson SG
    Ophthalmology; 2003 Mar; 110(3):549-58. PubMed ID: 12623820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double cone dystrophy and RPE degeneration in the retina of the zebrafish gnn mutant.
    Biehlmaier O; Neuhauss SC; Kohler K
    Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1287-98. PubMed ID: 12601061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease.
    Luiro K; Kopra O; Lehtovirta M; Jalanko A
    Hum Mol Genet; 2001 Sep; 10(19):2123-31. PubMed ID: 11590129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence.
    Mantel I; Brantley MA; Bellmann C; Robson AG; Holder GE; Taylor A; Anderson G; Moore AT
    Klin Monbl Augenheilkd; 2004 May; 221(5):427-30. PubMed ID: 15162299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis.
    Kitzmüller C; Haines RL; Codlin S; Cutler DF; Mole SE
    Hum Mol Genet; 2008 Jan; 17(2):303-12. PubMed ID: 17947292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues.
    Karakousis PC; John SK; Behling KC; Surace EM; Smith JE; Hendrickson A; Tang WX; Bennett J; Milam AH
    Mol Vis; 2001 Jun; 7():154-63. PubMed ID: 11438800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathology and functional correlations in a patient with a mutation in RPE65, the gene for retinol isomerase.
    Bonilha VL; Rayborn ME; Li Y; Grossman GH; Berson EL; Hollyfield JG
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8381-92. PubMed ID: 21931134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of mutations in the Batten disease gene, CLN3.
    Munroe PB; Mitchison HM; O'Rawe AM; Anderson JW; Boustany RM; Lerner TJ; Taschner PE; de Vos N; Breuning MH; Gardiner RM; Mole SE
    Am J Hum Genet; 1997 Aug; 61(2):310-6. PubMed ID: 9311735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function.
    Chandrachud U; Walker MW; Simas AM; Heetveld S; Petcherski A; Klein M; Oh H; Wolf P; Zhao WN; Norton S; Haggarty SJ; Lloyd-Evans E; Cotman SL
    J Biol Chem; 2015 Jun; 290(23):14361-80. PubMed ID: 25878248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel mutation af Cln3 associated with delayed-classic juvenile ceroid lipofuscinois and autophagic vacuolar myopathy.
    Licchetta L; Bisulli F; Fietz M; Valentino ML; Morbin M; Mostacci B; Oliver KL; Berkovic SF; Tinuper P
    Eur J Med Genet; 2015 Oct; 58(10):540-4. PubMed ID: 26360874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrastructural studies of the retina in infantile neuronal ceroid-lipofuscinosis.
    Goebel HH; Klein H; Santavuori P; Sainio K
    Retina; 1988; 8(1):59-66. PubMed ID: 3406546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further Characterization of the Predominant Inner Retinal Degeneration of Aging Cln3
    Volz C; Mirza M; Langmann T; Jägle H
    Adv Exp Med Biol; 2018; 1074():403-411. PubMed ID: 29721970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse.
    Philp NJ; Ochrietor JD; Rudoy C; Muramatsu T; Linser PJ
    Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1305-11. PubMed ID: 12601063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological Effects on Ceroid Lipofuscin and Neuronal Structure in Cln3
    Brenneman DE; Pearce DA; Kovacs A; DeFrees S
    J Mol Neurosci; 2017 Sep; 63(1):100-114. PubMed ID: 28812237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype.
    Kwon JM; Rothberg PG; Leman AR; Weimer JM; Mink JW; Pearce DA
    Neurosci Lett; 2005 Oct; 387(2):111-4. PubMed ID: 16087292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel in-frame mutation in
    Sher M; Farooq M; Abdullah U; Ali Z; Faryal S; Zakaria M; Ullah F; Bukhari H; Møller RS; Tommerup N; Baig SM
    Int J Neurosci; 2019 Sep; 129(9):890-895. PubMed ID: 30892110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.